1992
The Radionuclide Assessment of Left Ventricular Diastolic Filling: Methodology and Clinical Significance
SOUFER R, DEY H. The Radionuclide Assessment of Left Ventricular Diastolic Filling: Methodology and Clinical Significance. Echocardiography 1992, 9: 339-348. PMID: 10149890, DOI: 10.1111/j.1540-8175.1992.tb00475.x.Peer-Reviewed Original ResearchConceptsDiastolic fillingLeft ventricular diastolic fillingDiastolic heart failureVentricular diastolic fillingHypertensive heart diseaseCoronary artery diseaseAppropriate clinical contextArtery diseaseHeart failureDiastolic performanceHeart diseasePathophysiological presentationHypertrophic cardiomyopathyClinical significanceNoninvasive indexRadionuclide assessmentClinical settingRadionuclide methodsClinical contextDiseaseCardiomyopathyRadionuclide measurements
1990
Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
Setaro J, Zaret B, Schulman D, Black H, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. The American Journal Of Cardiology 1990, 66: 981-986. PMID: 2220622, DOI: 10.1016/0002-9149(90)90937-v.Peer-Reviewed Original ResearchConceptsCongestive heart failureNormal left ventricular systolic performanceLeft ventricular diastolic fillingLeft ventricular systolic performanceVentricular diastolic fillingVentricular systolic performanceDiastolic fillingBlood pressureHeart failureSystolic performanceAbnormal left ventricular diastolic fillingThallium-201 stress scintigraphyAbnormal diastolic fillingEDV/sHeart failure scoreSignificant valvular diseaseMean ejection fractionDiastolic blood pressureSystolic blood pressureLeft ventricular functionPeak filling rateOral verapamilExercise capacityPlacebo valuesSystolic function